AIIMS, Dr. Arvind Khushwaha files affidavit before Bombay High Court.

[Vaccine PIL]

Vaccine causes adverse events including death therefore no one can be forced to get vaccines. 

The vaccines are unable to prevent infection and does not stop transmission. 

Dr. Arvind Khushwaha has been made Respondent No. 11 in the PIL (ST.) 6218 of 2022 filed by Social Activist Feroze Mithiborwala. 

Bench of Bombay High Court headed by Chief Justice Shri. Dipankar Datta vide its order dated 14th March, 2022 had given directions to all respondents to file reply affidavit till Friday i.e. 18th March, 2022. 

 The Government Pleader informed Adv. Abhishek Mishra, the Counsel for petitioner that State’s reply is ready and can be filed in the registry after getting approval from the state authority. 

The reply affidavit of Dr. Arvind Khushwaha reads thus; 

“1. It is established beyond any doubt that Natural immunity is robust and long lasting and is far superior to vaccine induced immunity. 

2. A vast majority of the Indian population has already been exposed to the virus (approx 80%) also cuts down the risk of infection by natural immunity. 

3. Taking a vaccine is an individual choice and is voluntary as per MOHFW. 

4. The pandemic in India is almost over and the third wave was also quite mild with very little hospitalizations. 

5. The global evidence clearly demonstrates that vaccine is unable to prevent infection and does not help in cutting transmission. 

6. Vaccinations may result in adverse events including death of the vaccinated individual. Many such instances in thousands have already been reported. 

7. Mandating vaccine for citizens in the current situation is not unnecessary but also does not provide any additional benefit in view of points given in above paragraphs. 

8. Taking a vaccine is an Individual choice and is voluntary as per MOHFW and any restriction of personal freedom or discrimination based upon vaccination status is unjustified. 

9. The covid-19 disease is a respiratory virus causing flu like symptoms with survival of 99.9% and more and thus does not merit disproportionate measures.”